Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis B--a viral oncogene?].

Nina M Weis1, Kim Krogsgaard

  • 1H:S Hvidovre Hospital, infektionsmedicinsk afdeling, klinisk forskningsenhed, DK-2650 Hvidovre.

Ugeskrift for Laeger
|January 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity.

European journal of endocrinology·2022
Same author

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.

PloS one·2019
Same author

Mapping international impact of Danish neuroscience from 2004 to 2015 using tailored scientometric methodology.

The European journal of neuroscience·2017
Same author

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial.

The lancet. HIV·2016
Same author

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.

PLoS pathogens·2015
Same author

The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects.

Cytokine·2015
Same journal

Ugeskrift for laeger·2026
Same journal

[Financial support scheme following a recognised occupational injury].

Ugeskrift for laeger·2026
Same journal

[Foreign body granulomas in the lungs after several years of parenteral nutrition].

Ugeskrift for laeger·2026
Same journal

[Vaginal aids for stress incontinence].

Ugeskrift for laeger·2026
Same journal

[Osteodystrophy in chronic liver disease].

Ugeskrift for laeger·2026
Same journal

[Tympanic membrane perforation].

Ugeskrift for laeger·2026
See all related articles

Chronic hepatitis B virus infection can lead to liver cancer. This review explores the link between persistent hepatitis B virus infection and hepatocellular carcinoma development, examining epidemiological and molecular data.

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Context:

  • Hepatitis B virus (HBV) infection is a global health concern.
  • Chronic HBV infection is a major risk factor for liver diseases, including cirrhosis and hepatocellular carcinoma (HCC).
  • The precise mechanisms linking chronic HBV infection to HCC remain incompletely understood.

Purpose:

  • To elucidate the natural history of hepatitis B virus infection.
  • To present epidemiological, serological, and molecular evidence connecting chronic HBV infection to HCC development.
  • To explore the potential roles of HBV itself and virus-induced cellular alterations in malignant transformation.

Summary:

  • This article reviews the natural progression of hepatitis B virus infection.
  • It synthesizes epidemiological, serological, and molecular data to establish a correlation between chronic HBV infection and the incidence of hepatocellular carcinoma.

Related Experiment Videos

  • The review discusses the ongoing debate regarding whether the virus directly causes cancer or if it's due to cellular changes from persistent infection.

    • Impact:

    • Provides a comprehensive overview of the relationship between chronic hepatitis B virus infection and liver cancer.
    • Highlights the need for further research into the molecular mechanisms driving HBV-associated hepatocarcinogenesis.
    • Informs public health strategies for managing chronic HBV infection and preventing hepatocellular carcinoma.